{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T21:36:47Z","timestamp":1759959407874},"reference-count":34,"publisher":"Japanese Society of Internal Medicine","issue":"23","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2017]]},"DOI":"10.2169\/internalmedicine.9191-17","type":"journal-article","created":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T22:14:15Z","timestamp":1507673655000},"page":"3167-3172","source":"Crossref","is-referenced-by-count":3,"title":["The Relationship between the Serum Oxytocin Levels, Disease Activity, the ADLs and the QOL in Patients with Rheumatoid Arthritis"],"prefix":"10.2169","volume":"56","author":[{"given":"Yusuke","family":"Miwa","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Furuya","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Yanai","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Showa University Koto-Toyosu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Kasama","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Medicine, Showa University Koto-Toyosu Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Sanada","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Showa University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Dougados M, Soubrier M, Antunez A, et al. Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73: 62-68, 2014."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Margaretten ME, Katz P, Schmajuk G, Yelin E. Missed opportunities for depression screening in patients with arthritis in the United States. J Gen Intern Med 28: 1637-1642, 2013.","DOI":"10.1007\/s11606-013-2541-y"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Miwa Y, Isojima S, Saito M, et al. Comparative study of infliximab therapy and methotrexate monotherapy to improve the clinical effect in rheumatoid arthritis patients. Intern Med 55: 2581-2585, 2016.","DOI":"10.2169\/internalmedicine.55.6872"},{"key":"4","unstructured":"4. Cochran DM, Fallon D, Hill M, Frazier JA. The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings. Harv Rev Psychiatry 21: 219-247, 2013."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ozsoy S, Esel E, Kula M. Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment. Psychiatry Res 169: 249-252, 2009.","DOI":"10.1016\/j.psychres.2008.06.034"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Rotzinger S, Lovejoy DA, Tan LA. Behavioral effects of neuropeptides in rodent models of depression and anxiety. Peptides 31: 736-756, 2010.","DOI":"10.1016\/j.peptides.2009.12.015"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Strauss GP, Keller WR, Koenig JI, Gold JM, Frost KH, Buchanan RW. Plasma oxytocin levels predict social cue recognition in individuals with schizophrenia. Schizophr Res 162: 47-51, 2015.","DOI":"10.1016\/j.schres.2015.01.034"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shin NY, Park HY, Jung WH, et al. Effects of oxytocin on neural response to facial expressions in patients with schizophrenia. Neuropsychopharmacology 40: 1919-1927, 2015.","DOI":"10.1038\/npp.2015.41"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Abdulamir HA, Abdul-Rasheed OF, Abdulghani EA. Low oxytocin and melatonin levels and their possible role in the diagnosis and prognosis in Iraqi autistic children. Saudi Med J 37: 29-36, 2016.","DOI":"10.15537\/smj.2016.1.13183"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lawson EA, Holsen LM, Santin M, et al. Postprandial oxytocin secretion is associated with severity of anxiety and depressive symptoms in anorexia nervosa. J Clin Psychiatry 74: e451-e457, 2013.","DOI":"10.4088\/JCP.12m08154"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Xu XJ, Zhang HF, Shou XJ, et al. Prenatal hyperandrogenic environment induced autistic-like behavior in rat offspring. Physiol Behav 138: 13-20, 2015.","DOI":"10.1016\/j.physbeh.2014.09.014"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hoge EA, Pollack MH, Kaufman RE, Zak PJ, Simon NM. Oxytocin levels in social anxiety disorder. CNS Neurosci Ther 14: 165-170, 2008.","DOI":"10.1111\/j.1755-5949.2008.00051.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Karaiskos D, Mavragani CP, Sinno MH, et al. Psychopathological and personality features in primary Sj\u00f6gren's syndrome-associations with autoantibodies to neuropeptides. Rheumatology (Oxford) 49: 1762-1769, 2010.","DOI":"10.1093\/rheumatology\/keq158"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Anderberg UM, Uvnas-Moberg K. Plasma oxytocin levels in female fibromyalgia syndrome patients. Z Rheumatol 59: 373-379, 2000.","DOI":"10.1007\/s003930070045"},{"key":"15","unstructured":"15. Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69: 1580-1588, 2010."},{"key":"16","unstructured":"16. Aletaha D, Ward MM, Machold KP, Nell VP, Stamm T, Smolen JS. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 52: 2625-2636, 2005."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62, 1960.","DOI":"10.1136\/jnnp.23.1.56"},{"key":"18","unstructured":"18. Ziebland S, Fitzpatrick R, Jenkinson C, Mowat A. Comparison of two approaches to measuring change in health status in rheumatoid arthritis: the Health Assessment Questionnaire (HAQ) and modified HAQ. Ann Rheum Dis 51: 1202-1205, 1992."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 Health Survey for use in Japan. J Clin Epidemiol 51: 1037-1044, 1998.","DOI":"10.1016\/S0895-4356(98)00095-X"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Fukuhara S, Ware JE Jr, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 Health Survey. J Clin Epidemiol 51: 1045-1053, 1998.","DOI":"10.1016\/S0895-4356(98)00096-1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Nishi D, Hashimoto K, Noguchi H, Matsuoka Y. Serum neuropeptide Y in accident survivors with depression or posttraumatic stress disorder. Neurosci Res 83: 8-12, 2014.","DOI":"10.1016\/j.neures.2014.03.009"},{"key":"22","unstructured":"22. Scantamburlo G, Hansenne M, Geenen V, Legros JJ, Ansseau M. Additional intranasal oxytocin to escitalopram improves depressive symptoms in resistant depression: an open trial. Eur Psychiatry 30: 65-68, 2015."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Nishi D, Hashimoto K, Noguchi H, Kim Y, Matsuoka Y. Serum oxytocin, posttraumatic coping and C-reactive protein in motor vehicle accident survivors by gender. Neuropsychobiology 71: 196-201, 2015.","DOI":"10.1159\/000382021"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Cao C, Wang L, Wang R, Qing Y, Zhang J. Oxytocin is associated with PTSD's anxious arousal symptoms in Chinese male earthquake survivors. Eur J Psychotraumatol 5: 26530, 2014.","DOI":"10.3402\/ejpt.v5.26530"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Goldman M, Marlow-O'Connor M, Torres I, Carter CS. Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits. Schizophr Res 98: 247-255, 2008.","DOI":"10.1016\/j.schres.2007.09.019"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Sasaki T, Hashimoto K, Oda Y, et al. Decreased levels of serum oxytocin in pediatric patients with Attention Deficit\/Hyperactivity Disorder. Psychiatry Res 228: 746-751, 2015.","DOI":"10.1016\/j.psychres.2015.05.029"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Demirci E, Ozmen S, Kilic E, Oztop DB. The relationship between aggression, empathy skills and serum oxytocin levels in male children and adolescents with attention deficit and hyperactivity disorder. Behav Pharmacol 27: 681-688, 2016.","DOI":"10.1097\/FBP.0000000000000234"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Husarova VM, Lakatosova S, Pivovarciova A, et al. Plasma oxytocin in children with autism and its correlations with behavioral parameters in children and parents. Psychiatry Investig 13: 174-183, 2016.","DOI":"10.4306\/pi.2016.13.2.174"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Jansen LM, Gispen-de Wied CC, Wiegant VM, Westenberg HG, Lahuis BE, van Engeland H. Autonomic and neuroendocrine responses to a psychosocial stressor in adults with autistic spectrum disorder. J Autism Dev Disord 36: 891-899, 2006.","DOI":"10.1007\/s10803-006-0124-z"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Sasaki T, Hashimoto K, Oda Y, et al. Increased serum levels of oxytocin in 'Treatment Resistant Depression in Adolescents (TRDIA)' Group. PLoS One 11: e0160767, 2016.","DOI":"10.1371\/journal.pone.0160767"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Parker KJ, Kenna HA, Zeitzer JM, et al. Preliminary evidence that plasma oxytocin levels are elevated in major depression. Psychiatry Res 178: 359-362, 2010.","DOI":"10.1016\/j.psychres.2009.09.017"},{"key":"32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.psyneuen.2007.01.009","volume":"32","author":"G Scantamburlo","year":"2007","unstructured":"32. Scantamburlo G, Hansenne M, Fuchs S, et al. Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology 32: 407-410, 2007.","journal-title":"Psychoneuroendocrinology","ISSN":"http:\/\/id.crossref.org\/issn\/0306-4530","issn-type":"print"},{"key":"33","unstructured":"33. Kutake Y, Imamura Y, Mizogushi Y, et al. In female mild cognitive impairment and Alzheimer type dementia, peripheral oxytocin concentration is lower than healthy elderly. Jpn J Psychiatr Neurol (supple): S528, 2016 (in Japanese)."},{"key":"34","unstructured":"34. Gutkowska J, Jankowski M. Oxytocin: old hormone, new drug. Pharmaceuticals (Basel) 2: 168-183, 2009."}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/23\/56_9191-17\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T12:41:01Z","timestamp":1570192861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/56\/23\/56_9191-17\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":34,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.9191-17","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}